PBM (PBM) Stock Price & Analysis
PBM (PBM) fell 7.50% to USD 3.33 as of June 10, 2026 at 03:44 UTC, according to Nexqual real-time market data.
PBM last closed at USD 3.6; the session ranged USD 3.33–3.69 on volume of 49,672 shares. Market capitalization is $7.64M, with a 52-week range of USD 1.92–468.36 (NCM). Source: Nexqual, June 10, 2026 at 03:44 UTC.
Key Statistics (as of June 10, 2026 at 03:44 UTC)
| Price | USD 3.33 |
|---|---|
| Change | ▼ 7.50% (down) |
| Previous Close | USD 3.6 |
| Open | USD 3.64 |
| Day Range | USD 3.33 – 3.69 |
| 52-Week Range | USD 1.92 – 468.36 |
| Volume | 49,672 shares |
| Market Cap | $7.64M |
| Exchange | NCM |
Technical Analysis (PBM)
Nexqual's technical model rates PBM "SELL" based on 2 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 03:44 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 24.96 (oversold) |
| vs SMA50 | Below (USD 4.87) |
| MACD | -0.47 (negative) |
Analyst Ratings (PBM)
Wall Street analysts rate PBM "None", per Nexqual as of June 10, 2026 at 03:44 UTC.
| Consensus Rating | None |
|---|
Earnings (PBM)
Source: Nexqual, June 10, 2026 at 03:44 UTC.
Financials & Fundamentals (PBM)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -74.29% |
| Current Ratio | 8.09 |
| Total Cash | $7.15M |
| Total Debt | $0 |
| Free Cash Flow | $-4.01M |
Source: Nexqual, June 10, 2026 at 03:44 UTC.
Financial Health Score (PBM)
Nexqual rates PBM's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 03:44 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $7M cash, no debt |
| Cash Flow | Weak — Operating cash flow -$4M |
| Efficiency | Critical — ROE -74%, ROA -34.4% |
Ownership (PBM)
| Insider Ownership | +4.45% |
|---|---|
| Institutional Ownership | +6.68% |
| Shares Outstanding | 2.29M |
| Float | 142,968 |
| Short % of Float | +1.13% |
Source: Nexqual, June 10, 2026 at 03:44 UTC.
Leadership (PBM)
PBM is led by Jody Aufrichtig (age 51), Co-Founder, Executive Chairman & CEO, per Nexqual as of June 10, 2026 at 03:44 UTC.
| Co-Founder, Executive Chairman & CEO | Jody Aufrichtig (age 51) |
|---|---|
| CFO & Director | Warwick Ron Corden-Lloyd (age 45) |
Major Backers & Investors (PBM)
Notable institutional backers of PBM include Parallel Advisors, LLC, AdvisorShares Trust-AdvisorShares Psychedelics ETF, according to Nexqual as of June 10, 2026 at 03:44 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Parallel Advisors, LLC | 14.8% |
| AdvisorShares Trust-AdvisorShares Psychedelics ETF | 9.86% |
Source: Nexqual, June 10, 2026 at 03:44 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RENX | RenX Enterprises Corp. | USD 1.7 | ▼ 0.58% |
| GXAI | Gaxos.ai Inc. | USD 1.19 | ▼ 13.77% |
| MIRA | MIRA Pharmaceuticals, Inc. | USD 0.98 | ▼ 2.3% |
| CERO | CERo Therapeutics Holdings, Inc | USD 0.01 | ▼ 11.67% |
| CMND | Clearmind Medicine Inc. | USD 3.39 | ▼ 14.82% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:44 UTC. This page is informational and not investment advice.